USPTO serial 87099611
OXC-BETA
Reviewed by CopyMark Law Group
Reg. 5987095Status 710
- Filing date
- Status date
- Registration date
- Feb 18, 2020
- Examiner
- RINKER, ANTHONY MICHAEL
- Law office
- TMO LAW OFFICE 119
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with OXC-BETA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Ottawa, Ontario, CA
Ottawa, Ontario, CA
Ottawa, Ontario, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey J. Ellison
Jeffrey J. Ellison Clark+Elbing LLP101 Federal Street, 15th FloorBoston, MA 02110UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Adjuvants for use with vaccines; Animal feed additives and supplements; Anti-infective products for veterinary use; Anti-inflammatories; Dietary, nutritionals and food supplements; Nutritional supplements for general health and well-being; Dietary food supplements for general health and well-being; Medicated dermatological preparations and substances; Medicated skin care preparations; Non-medicated additives for animal feed for use as nutritional supplements; Nutritional supplements for supporting immune function; Nutritional supplements for cats, dogs, horses, livestock; Pharmaceutical preparations for treatment of infectious diseases, namely, respiratory infections, eye infections; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations and substances for the treatment of viral, respiratory, gastrointestinal, dermatological, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of bacteria-based diseases or disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of bacterial infections; Pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; Pharmaceutical preparations for the prevention and treatment of disorders of the immune system, Pharmaceutical preparations for treatment of respiratory diseases, disorders and infections; Pharmaceutical preparations for the treatment of inflammatory disorders and diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in gastroenterology; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for treating respiratory diseases; Veterinary preparations for treatment of intestinal bacteria; Veterinary pharmaceutical preparations for animals and poultry to give newborn animals and birds a healthy start; Veterinary pharmaceutical preparations for respiratory and reproductive diseases in cattle; Veterinary pharmaceutical preparations for treatment of bacterial infections in dogs; Veterinary pharmaceutical preparations for the treatment of infectious diseases in poultry; Veterinary pharmaceutical preparations for treatment of infectious disease, namely, respiratory infections, eye infections, topical infections; Veterinary pharmaceutical preparations for the treatment of infectious diseases, namely, swine dysentery, bacterial enteritis, bluecomb, pneumonia; Veterinary pharmaceutical preparations for the treatment of swine bacterial infectious diseases; Veterinary pharmaceutical preparations for treatment of intestinal bacteria | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 28, 2026 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Feb 18, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Feb 18, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 3, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 3, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 13, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 28, 2019 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 24, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 23, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 23, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 22, 2019 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Oct 11, 2019 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Oct 11, 2019 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Oct 11, 2019 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Sep 23, 2019 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Mar 18, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 18, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 18, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 26, 2019 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Aug 16, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Aug 16, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Aug 16, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Aug 1, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 1, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 31, 2018 | ALIE | ASSIGNED TO LIE | — |
| Jul 27, 2018 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jul 19, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 19, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 23, 2018 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| May 23, 2018 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| May 23, 2018 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| May 2, 2018 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Oct 18, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 18, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 18, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 27, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 27, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 26, 2017 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| May 22, 2017 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| May 22, 2017 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| May 22, 2017 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| May 9, 2017 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| May 5, 2017 | ALIE | ASSIGNED TO LIE | — |
| Oct 27, 2016 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 27, 2016 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 27, 2016 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 19, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 15, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 14, 2016 | NWAP | NEW APPLICATION ENTERED | — |